Skip to main content
Log in

Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

The objective of the study was to evaluate the ability of meropenem to reach the bronchial lumen. 24 patients undergoing fibreoptic bronchoscopy for exploratory purposes were given a single dose of meropenem 1 g as an (i.v.), infusion over 30 min. Plasma (P) sampling times were: 0, 0.5, 1, 2 and 3 h. Bronchial secretions (BS) were collected by fibreoptic bronchoscopy at the same sampling times (except for 0 and 0.5 h) in three groups of 8 patients. Meropenem was measured by bioassay using E. coli ATCC 39118 as the test-organism.

The results showed that meropenem had reached a high plasma concentration at the first sampling time (59.8 mg · 1−1) and then the plasma level decreased rapidly to 10.6 mg · 1−1 and 2.7 mg · 1−1 at 2 and 3 h respectively. The highest concentration achieved in bronchial secretion was 0.53 mg · 1−1 in the third hour, ie 20% of the serum level.

The data indicate significant penetration of meropenem into bronchial secretions and achievement of a local level sufficiently high to eradicate most respiratory pathogens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Barza M (1981) Principles of tissue penetration of antibiotics. J Antimicrob Chemother 8 [Suppl C]: 7–28

    Google Scholar 

  2. Bergogne-Bérézin E (1993) Pharmacokinetics of antibiotics in respiratory tissues and fluids. In Pennington JE (ed) Respiratory infections: diagnosis and management, 3d edn. Raven Press, New York (in press)

    Google Scholar 

  3. Honeybourne D, Baldwin DR (1992). The site concentrations of antimicrobial agents in the lung. J Antimicrob Chemother. 30: 249–260

    Google Scholar 

  4. Pennington JE (1981) Penetration of antibiotics into respiratory secretions. Rev Infect Dis 3: 67–73

    Google Scholar 

  5. Valcke Y, Pauwels R, Van der Streten M (1990) Pharmacokinetics of antibiotics in the lungs. Eur Respir J 3: 715–722

    Google Scholar 

  6. May JR, Delves DM (1965) Treatment of chronic bronchitis with ampicillin: some pharmacological observations. Lancet I: 929–933

    Google Scholar 

  7. Stewart SM, Anderson IME, Jones GR, Galder MA (1974) Amoxycillin levels in sputum, serum and saliva. Thorax 29: 110–114

    Google Scholar 

  8. Bergogne-Bérézin E, Muller-Serieys C, Kafé H (1992) Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration. Am J Med 92 [Suppl 4A]: 4A-8S

    Google Scholar 

  9. Ravizzola G, Pinsi G, Gonzales R, Colombrita D, Pirali F, Turano A (1989) Antibacterial activity of the new carbapenem meropenem (SM-7338) against clinical isolates. Eur J Clin Microbiol Infect Dis 8: 1053–1064

    Google Scholar 

  10. Chimata M, Nagase M, Suzuki Y, Shimomura M, Kakuta S (1993) Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease. Antimicrob Agents Chemother 37: 229–233

    Google Scholar 

  11. Nilsson-Ehjle I, Hutchison M, Haworth SJ, Norrby SR (1991) Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males. Eur J Clin Microbiol Infect Dis 10: 85–88

    Google Scholar 

  12. Bax RP, Bastain W, Featherstone A, Wilkinson DM, Hutchison M, Haworth SJ (1989) The pharmacokinetics of meropenem in volunteers. J Antimicrob Chemother 24 [Suppl A]: 311–320

    Google Scholar 

  13. Harrison MP, Moss R, Featherstone A, Fowkes AG, Sanders AM, Case DE (1989) The disposition and metabolism of meropenem in laboratory animals and man. J Antimicrob Chemother 24 [Suppl A]: 265–277

    Google Scholar 

  14. Wise R, Logan M, Cooper M, Ashby JP, Andrews JM (1990) Meropenem pharmacokinetics and penetration into an inflammatory exudate. Antimicrob Agents Chemother 34: 1515–1517

    Google Scholar 

  15. Muller-Serieys C, Bergogne-Bérézin E, Rowan C, Dombret MC (1987) Imipenem penetration into bronchial secretions. J Antimicrob Chemother 20: 618–619

    Google Scholar 

  16. Jones RN, Barry AL, Thornsberry C (1989) In vitro studies of meropenem. J Antimicrob Chemother 24 [Suppl A]: 9–29

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bergogne-Bérézin, E., Muller-Serieys, C., Aubier, M. et al. Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy. Eur J Clin Pharmacol 46, 87–88 (1994). https://doi.org/10.1007/BF00195922

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00195922

Key words

Navigation